translational longevity research

ARDD 2026 brings global pharma, FDA leaders and longevity science pioneers to Harvard October 1–3 — Photo by Jan van der Wolf

Reveal 5 Longevity Science Failures Blocking FDA Approval

Reveal 5 Longevity Science Failures Blocking FDA Approval In 2025, Harvard researchers showed a senolytic cocktail extended mouse healthspan by 23%, yet most anti-aging candidates never clear early regulatory hurdles. The five biggest failures that keep promising molecules stuck in petri dishes and mouse studies are safety validation gaps, weak